If not, you may not be alone. And the deadline to apply for and start using the 10-digit National Provider Identifier (NPI) is just a few months away.
If not, you may not be alone. And the deadline to apply for and start using the 10-digit National Provider Identifier (NPI) is just a few months away.
If you file a claim electronically with a public or private payer, or bill Medicare electronically or by paper, you must apply for and use the new NPI by May 23 or "run the risk of delayed or rejected claims," reported American Medical News (12/25/06). As the Centers for Medicare & Medicaid Services puts it: "Getting an NPI is free-not having one can be costly."
Yet despite the upcoming deadline, the health-care industry does not seem to be prepared for the switch to the new NPI, which will replace all other identifiers. A survey of members of the Workgroup of Electronic Data Interchange, which includes the American Medical Association as a corporate member, found that more than half would not have NPI capabilities until after April 1. This leaves little room to test billing and claims systems with the new identifiers. As a result, the workgroup is calling on the Centers for Medicare & Medicaid Services to allow the industry to use the old ID numbers for an additional year after the May deadline.
Until these issues are addressed, federal officials still encourage physicians to obtain their NPIs.
You can apply for the NPI online at http://nppes.cms.hhs.gov/ or by calling the NPI enumerator at (800) 465-3203 for a paper application to be completed.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More